drugset / Trial / NCT07145255
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a multicenter, open-label FIH, Phase 1a (dose escalation), Phase 1b (dose expansion) and Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment.
Timeline
- Start
- 2025-09-03
- Primary completion
- 2029-09-30
- Completion
- 2029-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MBRC-201 | Unknown | — | — |